Travere Therapeutics, Inc. (TVTX)
USD 15.0
(-9.42%)
USD 15.0
(-9.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 346.6 Million USD | 0.23% |
| 2022 | 345.8 Million USD | 259.34% |
| 2021 | 96.23 Million USD | -26.3% |
| 2020 | 130.56 Million USD | -8.33% |
| 2019 | 142.42 Million USD | 24.2% |
| 2018 | 114.67 Million USD | 311.12% |
| 2017 | -54.31 Million USD | -1688.22% |
| 2016 | 3.42 Million USD | -43.91% |
| 2015 | 6.09 Million USD | -90.7% |
| 2014 | 65.56 Million USD | 1193.31% |
| 2013 | -5.99 Million USD | -786.68% |
| 2012 | 873.37 Thousand USD | 4040.99% |
| 2011 | 21.09 Thousand USD | 0.23% |
| 2010 | 21.04 Thousand USD | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -604.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 370.93 Million USD | 2.82% |
| 2024 Q1 | 360.76 Million USD | 4.08% |
| 2024 Q3 | 366.02 Million USD | -1.32% |
| 2023 Q4 | 346.6 Million USD | 32.68% |
| 2023 Q1 | 245.46 Million USD | -29.01% |
| 2023 FY | 346.6 Million USD | 0.23% |
| 2023 Q3 | 261.23 Million USD | -22.09% |
| 2023 Q2 | 335.29 Million USD | 36.59% |
| 2022 Q3 | 256.28 Million USD | 12.2% |
| 2022 Q1 | 152.21 Million USD | 58.17% |
| 2022 Q2 | 228.41 Million USD | 50.06% |
| 2022 Q4 | 345.8 Million USD | 34.93% |
| 2022 FY | 345.8 Million USD | 259.34% |
| 2021 Q2 | 137.57 Million USD | 96.97% |
| 2021 FY | 96.23 Million USD | -26.3% |
| 2021 Q1 | 69.84 Million USD | -46.51% |
| 2021 Q3 | 73.36 Million USD | -46.67% |
| 2021 Q4 | 96.23 Million USD | 31.16% |
| 2020 Q4 | 130.56 Million USD | 972.86% |
| 2020 Q1 | 140.39 Million USD | -1.43% |
| 2020 FY | 130.56 Million USD | -8.33% |
| 2020 Q2 | -27.16 Million USD | -119.35% |
| 2020 Q3 | 12.17 Million USD | 144.81% |
| 2019 Q3 | 137.16 Million USD | 10.41% |
| 2019 FY | 142.42 Million USD | 24.2% |
| 2019 Q1 | 150.16 Million USD | 30.95% |
| 2019 Q2 | 124.23 Million USD | -17.27% |
| 2019 Q4 | 142.42 Million USD | 3.83% |
| 2018 Q1 | -15.87 Million USD | 70.77% |
| 2018 Q4 | 114.67 Million USD | 90.14% |
| 2018 Q3 | 60.31 Million USD | 237.37% |
| 2018 FY | 114.67 Million USD | 311.12% |
| 2018 Q2 | -43.9 Million USD | -176.49% |
| 2017 Q3 | -54.08 Million USD | -21.48% |
| 2017 Q1 | 2.71 Million USD | -20.7% |
| 2017 Q2 | -44.51 Million USD | -1741.52% |
| 2017 FY | -54.31 Million USD | -1688.22% |
| 2017 Q4 | -54.31 Million USD | -0.44% |
| 2016 Q3 | 20.36 Million USD | -11.23% |
| 2016 FY | 3.42 Million USD | -43.91% |
| 2016 Q2 | 22.93 Million USD | 10.98% |
| 2016 Q4 | 3.42 Million USD | -83.2% |
| 2016 Q1 | 20.66 Million USD | 238.97% |
| 2015 FY | 6.09 Million USD | -90.7% |
| 2015 Q1 | -35.93 Million USD | -154.8% |
| 2015 Q2 | -43.02 Million USD | -19.75% |
| 2015 Q3 | -96.84 Million USD | -125.08% |
| 2015 Q4 | 6.09 Million USD | 106.3% |
| 2014 Q4 | 65.56 Million USD | 14.17% |
| 2014 FY | 65.56 Million USD | 1193.31% |
| 2014 Q3 | 57.43 Million USD | 33.77% |
| 2014 Q2 | 42.93 Million USD | 55.62% |
| 2014 Q1 | 27.58 Million USD | 560.0% |
| 2013 Q3 | -13.39 Million USD | -4745.98% |
| 2013 Q1 | -2.49 Million USD | -11917.36% |
| 2013 Q4 | -5.99 Million USD | 55.24% |
| 2013 FY | -5.99 Million USD | -786.68% |
| 2013 Q2 | -276.51 Thousand USD | 88.91% |
| 2012 Q4 | 21.1 Thousand USD | 0.0% |
| 2012 FY | 873.37 Thousand USD | 4040.99% |
| 2012 Q1 | 21.09 Thousand USD | -0.09% |
| 2012 Q2 | 21.1 Thousand USD | 0.04% |
| 2012 Q3 | 21.1 Thousand USD | 0.0% |
| 2011 Q2 | 21.06 Thousand USD | 0.11% |
| 2011 Q1 | 21.04 Thousand USD | 0.0% |
| 2011 FY | 21.09 Thousand USD | 0.23% |
| 2011 Q4 | 21.1 Thousand USD | 0.09% |
| 2011 Q3 | 21.09 Thousand USD | 0.12% |
| 2010 FY | 21.04 Thousand USD | 0.0% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q2 | 15.16 Thousand USD | 0.0% |
| 2010 Q3 | 18.29 Thousand USD | 20.61% |
| 2009 FY | - USD | 100.0% |
| 2009 Q4 | 8879.00 USD | 54.82% |
| 2009 Q3 | 5735.00 USD | 125.7% |
| 2009 Q2 | 2541.00 USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | -5000.00 USD | 0.0% |
| 2008 Q3 | - USD | 100.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | -604.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 719.607% |
| Alkermes plc | -166.73 Million USD | 307.875% |
| Agenus Inc. | 274.13 Million USD | -26.437% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 81.464% |
| Aptorum Group Limited | 1.35 Million USD | -25441.36% |
| Ardelyx, Inc. | 34.51 Million USD | -904.312% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -7998.318% |
| Bicycle Therapeutics plc | -481.46 Million USD | 171.99% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -858.46% |
| ChromaDex Corporation | -24.04 Million USD | 1541.317% |
| Chimerix, Inc. | -25.51 Million USD | 1458.341% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -4874.228% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 1563.902% |
| CRISPR Therapeutics AG | -150.84 Million USD | 329.778% |
| Precision BioSciences, Inc. | -85.41 Million USD | 505.817% |
| Dyadic International, Inc. | -6.37 Million USD | 5534.347% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 2275.41% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4421.957% |
| Lantern Pharma Inc. | -21.7 Million USD | 1697.031% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 413.567% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 4157.133% |
| Incyte Corporation | -3.17 Billion USD | 110.916% |
| IO Biotech, Inc. | -140.69 Million USD | 346.347% |
| Jaguar Health, Inc. | 29.39 Million USD | -1079.3% |
| Novavax, Inc. | -298.29 Million USD | 216.197% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -6394.435% |
| Opthea Limited | 28.15 Million USD | -1130.964% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 2164.495% |
| ContextLogic Inc. | -232 Million USD | 249.4% |
| MiMedx Group, Inc. | -33.9 Million USD | 1122.412% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -3299.784% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 15059.17% |
| NextCure, Inc. | -6.47 Million USD | 5451.366% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 786.339% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 5533.579% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -2749.629% |
| Vaxcyte, Inc. | -368.22 Million USD | 194.129% |
| PDS Biotechnology Corporation | -32.7 Million USD | 1159.675% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -1906.066% |
| Pharming Group N.V. | 109.8 Million USD | -215.661% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 2092.458% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 297.802% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1971.548% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1971.548% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 4981.803% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 6014.812% |
| Acelyrin, Inc. | -216.9 Million USD | 259.799% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 6278.102% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 20204.872% |
| Summit Therapeutics Inc. | 34.67 Million USD | -899.619% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 5194.929% |
| Senti Biosciences, Inc. | 1.74 Million USD | -19820.0% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 287.755% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 547.519% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 5817.717% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -347310.518% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -55092.357% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 396.13% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 306.029% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -212.626% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 4663.033% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 368.451% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -4927.24% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 243.012% |
| Immix Biopharma, Inc. | -17.5 Million USD | 2079.51% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 209.443% |
| MEI Pharma, Inc. | -3.7 Million USD | 9455.142% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -2670.426% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -114.297% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -1147.105% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4421.957% |
| Precigen, Inc. | -481 Thousand USD | 72159.875% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -2361.53% |
| AlloVir, Inc. | -62.69 Million USD | 652.874% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 723.239% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -462.073% |
| ImmuCell Corporation | 10.99 Million USD | -3053.688% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 324.857% |
| Onconetix, Inc. | 5.33 Million USD | -6401.212% |
| PureTech Health plc | -167.19 Million USD | 307.305% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 1237.912% |
| Elevation Oncology, Inc. | -19.11 Million USD | 1912.993% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 7160.664% |
| Seer, Inc. | -4.24 Million USD | 8274.717% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 1541.977% |
| Innoviva, Inc. | 255.56 Million USD | -35.625% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 720.45% |
| ESSA Pharma Inc. | -33.62 Million USD | 1130.909% |
| GlycoMimetics, Inc. | -40.98 Million USD | 945.707% |
| GT Biopharma, Inc. | -1.02 Million USD | 34047.894% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 611.349% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -465.826% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 358.51% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 2601.501% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 1300.499% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 460195.043% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 1223.09% |
| Aptose Biosciences Inc. | -8.19 Million USD | 4329.58% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 11177.213% |
| Soligenix, Inc. | -4.95 Million USD | 7099.923% |
| Century Therapeutics, Inc. | 847 Thousand USD | -40821.842% |
| Kura Oncology, Inc. | -20.11 Million USD | 1822.875% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 946.914% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 4227.268% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -18926.676% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 10941.664% |
| Autolus Therapeutics plc | -186.59 Million USD | 285.75% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 803.002% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 225.676% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -911.463% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -110.873% |
| GRI Bio, Inc. | -1.79 Million USD | 19420.401% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 3958.468% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 1142.211% |
| IGM Biosciences, Inc. | -72.6 Million USD | 577.382% |
| INmune Bio, Inc. | -25.41 Million USD | 1464.008% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -129.616% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 784.198% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2233.055% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 12114.45% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -811.766% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 941.588% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -987.057% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 8.293% |
| Verastem, Inc. | -37.27 Million USD | 1029.792% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 3920.214% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 768.327% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 2390.109% |
| Histogen Inc. | -7.48 Million USD | 4729.464% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 1704.16% |
| Surrozen, Inc. | -32.66 Million USD | 1161.132% |
| Organovo Holdings, Inc. | -1.5 Million USD | 23099.867% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 8345.724% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -1728.081% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -13149.541% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -8239.942% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 4235.566% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 897.864% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 2477.796% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 209.413% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 48102.659% |
| Apollomics, Inc. | -27.39 Million USD | 1365.224% |
| Amarin Corporation plc | -191.04 Million USD | 281.432% |
| Mesoblast Limited | 55.96 Million USD | -519.352% |
| Turnstone Biologics Corp. | -14.58 Million USD | 2476.632% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 1470.425% |
| Synaptogenix, Inc. | -28.66 Million USD | 1309.316% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 37130.769% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -611.253% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 40305.594% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 4870.22% |
| Exelixis, Inc. | -73.05 Million USD | 574.48% |
| Better Therapeutics, Inc. | -860 Thousand USD | 40403.256% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 1543.418% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 243.6% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -46989.256% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 4759.878% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -27540.191% |
| Gritstone bio, Inc. | 39.49 Million USD | -777.711% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 512.133% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 13268.297% |
| Avid Bioservices, Inc. | 169.72 Million USD | -104.214% |
| Insmed Incorporated | 721.62 Million USD | 51.968% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 3891.583% |
| MediWound Ltd. | -5.32 Million USD | 6612.74% |
| OmniAb, Inc. | 9.2 Million USD | -3666.25% |
| Alector, Inc. | -35.63 Million USD | 1072.607% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -303.169% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 7133.442% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -2518.083% |
| Zai Lab Limited | -775 Million USD | 144.724% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -1.777% |
| Aura Biosciences, Inc. | -21.52 Million USD | 1710.258% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 520.233% |
| Immunic, Inc. | -45.34 Million USD | 864.464% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 279.39% |
| Veracyte, Inc. | -203.82 Million USD | 270.053% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 45.698% |
| FibroGen, Inc. | 56.76 Million USD | -510.58% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3792.285% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 12360.274% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 16841.533% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 92.449% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 10474.379% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 308.845% |
| TG Therapeutics, Inc. | 17.86 Million USD | -1840.477% |
| Galecto, Inc. | -21.21 Million USD | 1733.71% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 1557.255% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 77.915% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 1516.345% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 3112.149% |
| XBiotech Inc. | -200.02 Million USD | 273.284% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 512.133% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -7554.77% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1082.923% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 548.869% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -5990.459% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 303.391% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 475.222% |
| Vaxxinity, Inc. | 10.13 Million USD | -3320.924% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 52.924% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 3319.005% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 625.514% |
| NexImmune, Inc. | -3.13 Million USD | 11160.864% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 10138.831% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 2393.678% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 1378.996% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 3961.475% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 278332.39% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 954.303% |
| Ainos, Inc. | 4.07 Million USD | -8399.611% |
| Pluri Inc. | 22.82 Million USD | -1418.279% |
| Prothena Corporation plc | -608.34 Million USD | 156.975% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 391.866% |
| Celularity Inc. | 65.19 Million USD | -431.689% |
| Rallybio Corporation | -24.1 Million USD | 1538.088% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1124.891% |
| MeiraGTx Holdings plc | -40.3 Million USD | 960.027% |
| Omeros Corporation | 331.17 Million USD | -4.66% |
| Humacyte, Inc. | -22.48 Million USD | 1641.439% |
| Immunocore Holdings plc | -358.59 Million USD | 196.658% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 1510.409% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 1221.672% |
| Blueprint Medicines Corporation | 702.83 Million USD | 50.684% |
| CalciMedica, Inc. | -5.53 Million USD | 6367.776% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 284.15% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 3493.46% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 965.719% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 1142.336% |
| Pulmatrix, Inc. | -10.41 Million USD | 3427.33% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 5899.03% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 1008.731% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 411.133% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 678.22% |
| Cytokinetics, Incorporated | 642.37 Million USD | 46.042% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 6052.396% |
| Nutriband Inc. | -251.65 Thousand USD | 137830.323% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1115.88% |
| Vor Biopharma Inc. | 4.3 Million USD | -7960.651% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 105.742% |
| Evogene Ltd. | -19.63 Million USD | 1865.346% |
| ProKidney Corp. | -56.23 Million USD | 716.345% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 812.13% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 3852.311% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 74.587% |
| CorMedix Inc. | -43.05 Million USD | 905.082% |
| BioLineRx Ltd. | 7.33 Million USD | -4624.755% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 1361.999% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -651.095% |
| Atai Life Sciences N.V. | -28.55 Million USD | 1313.698% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -15439.273% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 1619.144% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -1854.373% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 561.688% |
| MediciNova, Inc. | -50.78 Million USD | 782.521% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 539.83% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1540922.405% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5471.611% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 273.459% |
| Biomea Fusion, Inc. | -166.57 Million USD | 308.085% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 293.663% |
| Mereo BioPharma Group plc | -51.46 Million USD | 773.431% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 465.451% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 217.991% |
| Absci Corporation | -72.59 Million USD | 577.435% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7491.064% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 247.847% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 467.906% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 462.197% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 987.078% |
| Allakos Inc. | -24.97 Million USD | 1487.82% |
| Imunon, Inc. | -4.21 Million USD | 8325.443% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 2451.16% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 355.988% |
| BioAtla, Inc. | -109.01 Million USD | 417.957% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -46989.256% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 37012.46% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -2796.607% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 1734.712% |
| XOMA Corporation | -29 Million USD | 1295.2% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 2193.043% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 3944.366% |
| aTyr Pharma, Inc. | -7.44 Million USD | 4753.081% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 378.096% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 266.507% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 523.835% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 473.649% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 40441.533% |
| Akari Therapeutics, Plc | -3.84 Million USD | 9114.512% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -21257.455% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 74.899% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 29272.443% |
| UroGen Pharma Ltd. | 4.39 Million USD | -7793.601% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -205.433% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -481554.206% |
| Orgenesis Inc. | 21.78 Million USD | -1491.113% |
| Entera Bio Ltd. | -10.62 Million USD | 3360.965% |
| GH Research PLC | -78.07 Million USD | 543.931% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 1655.133% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 1400.154% |
| Xencor, Inc. | 29.64 Million USD | -1069.235% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 17695.994% |
| Replimune Group, Inc. | 1.41 Million USD | -24447.309% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 141625.797% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 374.178% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 29272.443% |
| Portage Biotech Inc. | -4.98 Million USD | 7058.603% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1540922.405% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 624.195% |
| OncoCyte Corporation | -6.56 Million USD | 5381.243% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -38523.02% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 7708.322% |
| Purple Biotech Ltd. | -14.13 Million USD | 2551.606% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 1559.034% |
| scPharmaceuticals Inc. | -6.54 Million USD | 5395.768% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 2176.471% |
| HilleVax, Inc. | -165.48 Million USD | 309.45% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 13756.738% |
| Tharimmune, Inc. | -10.93 Million USD | 3269.61% |
| Genprex, Inc. | -6.73 Million USD | 5244.362% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 193.981% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 491.825% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 24840.043% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 10549.612% |
| OKYO Pharma Limited | -826.84 Thousand USD | 42019.192% |
| Savara Inc. | 153 Thousand USD | -226441.176% |
| Curis, Inc. | -23.88 Million USD | 1551.032% |
| Daré Bioscience, Inc. | -5.15 Million USD | 6819.93% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 44765.289% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 5683.247% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -29149.62% |
| BeiGene, Ltd. | -2.25 Billion USD | 115.384% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -2709.158% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 156.989% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 286.764% |
| Erasca, Inc. | -37.21 Million USD | 1031.341% |
| bluebird bio, Inc. | 108.57 Million USD | -219.245% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 27012.795% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 8.486% |
| DBV Technologies S.A. | -126.98 Million USD | 372.95% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 27012.795% |
| Moderna, Inc. | -2.9 Billion USD | 111.923% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 3448.223% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 3289.253% |
| Molecular Templates, Inc. | 707 Thousand USD | -48925.177% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 1204.868% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 522.373% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 477.857% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 1174.021% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1108.285% |
| MacroGenics, Inc. | -66.98 Million USD | 617.441% |
| RenovoRx, Inc. | -1.17 Million USD | 29648.849% |
| Adicet Bio, Inc. | -138.78 Million USD | 349.741% |
| Prime Medicine, Inc. | -27.94 Million USD | 1340.5% |
| Aditxt, Inc. | 18.12 Million USD | -1812.754% |
| Adagene Inc. | -87.62 Million USD | 495.548% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8421.066% |
| Quantum-Si incorporated | -118.55 Million USD | 392.356% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -862.666% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 4737.4% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 814.523% |
| SciSparc Ltd. | -2.06 Million USD | 16884.891% |
| Vericel Corporation | 1.27 Million USD | -27042.365% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2990.399% |
| Minerva Neurosciences, Inc. | 41 Million USD | -745.298% |
| Generation Bio Co. | 31.44 Million USD | -1002.162% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 297.651% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 1220.874% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -197.28% |
| Invivyd, Inc. | -198.47 Million USD | 274.635% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 483.968% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 14555.924% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 589.628% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 5178.505% |
| 2seventy bio, Inc. | 181.71 Million USD | -90.743% |
| ADMA Biologics, Inc. | 90.06 Million USD | -284.838% |
| Clene Inc. | 3.34 Million USD | -10277.485% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 3916.133% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 1711.306% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5471.611% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 200.722% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 1433.124% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -95.09% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 8571.278% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -6829.388% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 6754.022% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 366.0% |
| Evaxion Biotech A/S | 5.28 Million USD | -6456.047% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 407.91% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 364.036% |
| Trevena, Inc. | 2.25 Million USD | -15250.221% |
| Surrozen, Inc. | -32.66 Million USD | 1161.132% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 772.895% |
| Cingulate Inc. | 3.08 Million USD | -11143.712% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 11901.43% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -4722.708% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 3830.487% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 536.958% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 363.676% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 428.408% |
| Clearmind Medicine Inc. | -3.94 Million USD | 8891.273% |
| Kronos Bio, Inc. | -36.05 Million USD | 1061.358% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -3583.792% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -23670.769% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 738.838% |
| Statera Biopharma, Inc. | 14.41 Million USD | -2304.261% |
| ImmunityBio, Inc. | 618.22 Million USD | 43.935% |
| Korro Bio, Inc. | -132.94 Million USD | 360.719% |
| Kineta, Inc. | -4.54 Million USD | 7732.856% |
| BioVie Inc. | -17.73 Million USD | 2054.665% |
| Codexis, Inc. | -43.27 Million USD | 901.017% |
| Celularity Inc. | 65.19 Million USD | -431.689% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 11037.457% |
| Celcuity Inc. | 6.78 Million USD | -5009.568% |
| Virax Biolabs Group Limited | -3.36 Million USD | 10400.558% |
| Cibus, Inc. | -8.07 Million USD | 4390.765% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 8295.98% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -7484.42% |
| IN8bio, Inc. | -16.38 Million USD | 2214.882% |
| Kodiak Sciences Inc. | -103.87 Million USD | 433.678% |
| Annexon, Inc. | -193.75 Million USD | 278.89% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -962700.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 2080.73% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 9966.439% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 67.124% |
| Eyenovia, Inc. | 1.25 Million USD | -27436.939% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -1188.266% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10787.882% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 1142.524% |
| Arcellx, Inc. | -296.95 Million USD | 216.72% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 1876.93% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 688.718% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 1772.254% |
| Moolec Science SA | 117.61 Thousand USD | -294594.599% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 1002.649% |
| Geron Corporation | 14.76 Million USD | -2248.134% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 1014.099% |
| Royalty Pharma plc | 5.65 Billion USD | 93.874% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 345.089% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 5059.035% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 6563.12% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 346.291% |
| Humacyte, Inc. | -22.48 Million USD | 1641.439% |
| Structure Therapeutics Inc. | -124.33 Million USD | 378.76% |
| 89bio, Inc. | -289.05 Million USD | 219.912% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 1473.14% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 19539.596% |
| Genelux Corporation | -6.89 Million USD | 5124.032% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 1215.966% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -314.608% |
| Notable Labs, Ltd. | -9.77 Million USD | 3645.499% |
| Liquidia Corporation | -80.17 Million USD | 532.309% |
| Mustang Bio, Inc. | -3.73 Million USD | 9377.516% |
| Immunovant, Inc. | -635.22 Million USD | 154.564% |
| Quantum-Si incorporated | -118.55 Million USD | 392.356% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 2073.4% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 8466.112% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -4218.027% |
| Acasti Pharma Inc. | -23 Million USD | 1606.664% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 10393.568% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2233.055% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 351.639% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 11222.2% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 1659.05% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 1966.595% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 304.757% |
| PepGen Inc. | -60.67 Million USD | 671.3% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 1608.565% |
| United Therapeutics Corporation | -507.7 Million USD | 168.27% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 1912.235% |
| Solid Biosciences Inc. | -47.75 Million USD | 825.881% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 40305.594% |
| Immuneering Corporation | -54.94 Million USD | 730.852% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 8345.724% |
| Silo Pharma, Inc. | -3.52 Million USD | 9934.782% |
| Belite Bio, Inc | -87.27 Million USD | 497.163% |
| XOMA Corporation | -29 Million USD | 1295.2% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 590.273% |
| Bionomics Limited | 227 Million USD | -52.684% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 398.075% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13783.695% |
| uniQure N.V. | -102.95 Million USD | 436.673% |
| Cassava Sciences, Inc. | -121.13 Million USD | 386.131% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8421.066% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -746.397% |
| Forte Biosciences, Inc. | -11.96 Million USD | 2997.818% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 11301.862% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -326888.679% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10787.882% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3792.285% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 4773.786% |
| Altimmune, Inc. | -134.48 Million USD | 357.726% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -74.997% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13783.695% |
| Compugen Ltd. | -12.9 Million USD | 2786.051% |
| Peak Bio, Inc. | 10.34 Million USD | -3252.057% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 122576.325% |
| Benitec Biopharma Inc. | -50.58 Million USD | 785.24% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 432.197% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -1664.357% |
| Zura Bio Limited | -99.8 Million USD | 447.282% |
| PolyPid Ltd. | 6.17 Million USD | -5517.634% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -367.631% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -1664.357% |
| Instil Bio, Inc. | 75.35 Million USD | -359.949% |
| argenx SE | -2.02 Billion USD | 117.084% |
| Immunome, Inc. | -97.02 Million USD | 457.221% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 1640.822% |
| Verona Pharma plc | -220.44 Million USD | 257.232% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 583.124% |
| Shattuck Labs, Inc. | -121.42 Million USD | 385.453% |
| CervoMed Inc. | -7.79 Million USD | 4547.772% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 286.852% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 8026.092% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 363.1% |
| Moolec Science SA | 117.61 Thousand USD | -294594.599% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 15249.103% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -2080.147% |
| AnaptysBio, Inc. | -18.15 Million USD | 2009.581% |
| Design Therapeutics, Inc. | -18.15 Million USD | 2009.686% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 592.474% |
| NeurAxis, Inc. | 145.7 Thousand USD | -237791.558% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -2985.897% |
| Lumos Pharma, Inc. | -28.49 Million USD | 1316.467% |
| Achilles Therapeutics plc | -126.92 Million USD | 373.083% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 583.124% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 52958.341% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 1768.484% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -23670.769% |
| Nutriband Inc. | -251.65 Thousand USD | 137830.323% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 2731.6% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 4758.71% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -1.884% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -1360.324% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 177.459% |
| Palisade Bio, Inc. | -12.06 Million USD | 2973.315% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 347.028% |
| Beam Therapeutics Inc. | -262.72 Million USD | 231.93% |
| Neurogene Inc. | -131.95 Million USD | 362.671% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -1488.779% |
| AEON Biopharma, Inc. | -4.88 Million USD | 7202.623% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 191.892% |
| Sesen Bio, Inc. | -112.55 Million USD | 407.951% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 447.094% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 14863.141% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 988.146% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 516.186% |
| Athira Pharma, Inc. | -88.99 Million USD | 489.452% |
| Vaccinex, Inc. | -1.28 Million USD | 27010.559% |
| HCW Biologics Inc. | 2.85 Million USD | -12033.263% |
| XOMA Corporation | -29 Million USD | 1295.2% |
| Nektar Therapeutics | 210.24 Million USD | -64.863% |
| Arvinas, Inc. | -313.8 Million USD | 210.455% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -21257.455% |
| Merus N.V. | -192.88 Million USD | 279.698% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -477.824% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 5095.791% |
| Rezolute, Inc. | -68.16 Million USD | 608.461% |
| Clene Inc. | 3.34 Million USD | -10277.485% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 2728.407% |
| BeyondSpring Inc. | -13.75 Million USD | 2619.869% |
| Synlogic, Inc. | -6.68 Million USD | 5284.862% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -30465.079% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 4199.444% |
| Peak Bio, Inc. | 10.34 Million USD | -3252.057% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 520.539% |
| Krystal Biotech, Inc. | -350.23 Million USD | 198.965% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -179.241% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 305.098% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 11078.53% |
| MannKind Corporation | 143.89 Million USD | -140.869% |
| Ikena Oncology, Inc. | -109.15 Million USD | 417.535% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 4678.101% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 1147.154% |
| Gossamer Bio, Inc. | 180.35 Million USD | -92.181% |
| CohBar, Inc. | -5.93 Million USD | 5944.271% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 1265.147% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7491.064% |
| Legend Biotech Corporation | -949.39 Million USD | 136.508% |
| Mural Oncology plc | -255.84 Million USD | 235.477% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -975.921% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 7457.978% |
| Disc Medicine, Inc. | -358.28 Million USD | 196.742% |
| Champions Oncology, Inc. | 4.81 Million USD | -7102.993% |
| REGENXBIO Inc. | 54.76 Million USD | -532.866% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 128995.12% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 329.505% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 3946.069% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 529.592% |
| Vaxart, Inc. | -8.24 Million USD | 4305.897% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 790.73% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 372.564% |
| Cellectis S.A. | -43.85 Million USD | 890.35% |
| Longeveron Inc. | -2.9 Million USD | 12019.12% |
| Repare Therapeutics Inc. | -107.85 Million USD | 421.356% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 64.207% |
| Inozyme Pharma, Inc. | 12 Million USD | -2787.438% |
| Revolution Medicines, Inc. | -608.2 Million USD | 156.989% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 28279.512% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 230.738% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 330.961% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 2315.172% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 46938.919% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 103.624% |
| Denali Therapeutics Inc. | -74.86 Million USD | 562.977% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2990.399% |
| Veru Inc. | 4.77 Million USD | -7151.26% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 3182.056% |
| Cingulate Inc. | 3.08 Million USD | -11143.712% |
| Passage Bio, Inc. | 4.58 Million USD | -7459.607% |
| Context Therapeutics Inc. | -14.44 Million USD | 2498.7% |
| Exicure, Inc. | 5.84 Million USD | -5825.936% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 250.453% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 975.936% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -2108.961% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 689.259% |
| Nuvalent, Inc. | -335.38 Million USD | 203.346% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -19884.997% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 565.358% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 3998.853% |
| OmniAb, Inc. | 9.2 Million USD | -3666.25% |
| Anew Medical, Inc. | 1.43 Million USD | -24096.612% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -2015.817% |
| Lipocine Inc. | -4.75 Million USD | 7389.963% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 415.592% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -2175.675% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 784.198% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -1292.447% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 5257.09% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 626.544% |
| Ocugen, Inc. | -32.52 Million USD | 1165.797% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 505.034% |
| Q32 Bio Inc. | -37.94 Million USD | 1013.376% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 55292.357% |
| Alumis Inc. Common Stock | -13.52 Million USD | 2661.963% |
| Equillium, Inc. | -22.39 Million USD | 1647.91% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 1455.632% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 1162.342% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 139909.209% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -158.582% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -10738.274% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -105431.283% |
| Dominari Holdings Inc. | 195 Thousand USD | -177647.692% |
| Edesa Biotech, Inc. | -5.26 Million USD | 6680.861% |
| vTv Therapeutics Inc. | -8.91 Million USD | 3987.047% |
| Bio-Techne Corporation | 267.74 Million USD | -29.454% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 2238.368% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 393.502% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 4224.813% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 2839.768% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 241.404% |
| Nkarta, Inc. | 57.29 Million USD | -504.911% |
| BioCardia, Inc. | 212 Thousand USD | -163394.34% |
| Iterum Therapeutics plc | 13.43 Million USD | -2479.312% |